BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Profile — Insider Trades & Financials

Revenue$874.6M

Net Income-$46.6M

EPS$1.80

Market Cap$10.8B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Alexander Hardy

CEO & Executive Director

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).

Employees: 3,401
Headquarters: NOVATO, CA, United States
Website: www.biomarin.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-0.77%

ROA?

-0.61%

D/E Ratio?

0.25

Op. Margin?

-5.10%

📊

Profitability Ratios

Net Margin?

-5.33%

Loading company sections...

BIOMARIN PHARMACEUTICAL INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness